Filing Details

Accession Number:
0001209191-14-037251
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-27 19:41:18
Reporting Period:
2014-05-14
Filing Date:
2014-05-27
Accepted Time:
2014-05-27 19:41:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130591 Xenoport Inc XNPT Pharmaceutical Preparations (2834) 943330837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296771 Gordon John Freund 525 University Avenue, Ste. 520
C/O Skyline Ventures
Palo Alto CA 94301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-14 5,000 $0.00 8,899 No 4 M Direct
Common Stock Acquisiton 2014-05-22 5,500 $3.75 11,700 No 4 P Indirect Beneficial Ownership
Common Stock Acquisiton 2014-05-23 9,500 $3.72 21,200 No 4 P Indirect Beneficial Ownership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 P Indirect Beneficial Ownership
No 4 P Indirect Beneficial Ownership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-employee director stock unit Disposition 2014-05-14 5,000 $0.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 489,469 Indirect Through Fund
Common Stock 10,133 Indirect Beneficial Ownership
Common Stock 3,645 Indirect Beneficial Ownership
Common Stock 3,080 Indirect Beneficial Ownership
Common Stock 27 Indirect Beneficial Ownership
Footnotes
  1. 5,000 shares previously owned directly were contributed to Skyline Venture Partners V, L.P. John G. Freund is connected to Skyline Venture Partners V, L.P. as managing director or managing member either directly or through indirect ownership and in such capacity may be deemed to have voting and investment power with respect to shares held by this entity. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
  2. The shares are owned by a revocable trust of which John G. Freund is a trustee.
  3. These shares are held by multiple entities. 22 shares are held by Skyline Venture Partners III, L.P., 887 shares are held by Skyline Venture Partners Qualified Purchasers Fund III, L.P., 227 shares are held by Skyline Venture Management III, L.L.C. and 488,333 shares are held by Skyline Venture Partners V, L.P. John G. Freund is connected to each of these entities as managing director or managing member either directly or through indirect ownership and in such capacity may be deemed to have voting and investment power with respect to shares held by each of these entities. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
  4. The shares are owned by a retirement account of which John G. Freund is the beneficiary.
  5. The shares are held by the Paul Brooke 1989 Insurance Trust of which John G. Freund is a trustee.
  6. The shares are held by John G. Freund as custodian for his two sons.
  7. The shares are held by John G. Freund Family Partnership IV, L.P. John G. Freund disclaims beneficial ownership of such securities, except to the extent of his proportionate partnership interest therin.
  8. Each restricted stock unit represents a contingent right to receive one share of XenoPort, Inc. common stock.
  9. The restricted stock units shall cliff vest in full on the one-year anniversary of the grant date, May 14, 2013.